Site Menu
Search Close Search
Search Close Search
Page Menu
Getting Results…
  • UMass Chan Medical School licenses exNA oligonucleotide technology to Hongene Biotech Corporation

    UMass Chan Medical School licenses exNA oligonucleotide technology to Hongene Biotech Corporation

    UMass Chan Medical licenses exNA oligonucleotide technology to Hongene Biotech Corporation

    Read more
  • Novel siRNA backbone developed at UMass Chan enhances stability, durability of potentially therapeutic platform

    Novel siRNA backbone developed at UMass Chan enhances stability, durability of potentially therapeutic platform

    A biochemical breakthrough using simple carbon atoms by Ken Yamada, PhD, and Anastasia Khvorova, PhD, has dramatically improved the stability and efficacy of a potential oligonucleotide therapeutic platform in mice.

    Read more